IDH2 and central nervous system cancer: In addition, the frequency of IDH mutation strongly correlates with the tumor type, i.e., IDH mutations exist at a much higher frequency in lower grade gliomas than glioblastomas; therefore, there is a need to remove tumor type as a confounding factor in IDH mutation status.